Načítá se...
Protracted p53-independent stimulation of p21(WAF1/Cip1) fuels genomic instability by deregulating the replication licensing machinery
The cyclin-dependent kinase inhibitor p21(WAF1/Cip1) is the prototype downstream effector of the tumor suppressor protein p53. Yet, evidence from human cancer and mice models, imply that p21(WAF1/Cip1), under certain conditions, can exercise oncogenic activity. The mechanism behind this behavior is...
Uloženo v:
| Vydáno v: | Nat Cell Biol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6535144/ https://ncbi.nlm.nih.gov/pubmed/27323328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncb3378 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|